GENOMICS ENGLAND LIMITED

Active London

Research and experimental development on biotechnology

540 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
G

GENOMICS ENGLAND LIMITED

Research and experimental development on biotechnology

Founded 17 Apr 2013 Active London, England 540 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 31 Dec 2026 8 months remaining
Confirmation
Net assets £63M £36M 2024 year on year
Total assets £88M £39M 2024 year on year
Total Liabilities £25M £3M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Level 21 One Canada Square Canada Square London E14 5AB England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for GENOMICS ENGLAND LIMITED (08493132), an active life sciences and medical technology company based in London, England. Incorporated 17 Apr 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£57.93M

Increased by £37.94M (+190%)

Net Assets

£62.97M

Increased by £36.04M (+134%)

Total Liabilities

£25.47M

Increased by £3.26M (+15%)

Turnover

£29.94M

Increased by £728.18k (+2%)

Employees

540

Increased by 23 (+4%)

Debt Ratio

29%

Decreased by 16 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

20 Allotments 855,200,000 Shares £855.20m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Jan 202680,000,000£80.00m£1
7 Jul 202580,000,000£80.00m£1
3 Feb 202550,000,000£50.00m£1
23 Sept 202450,000,000£50.00m£1
30 Apr 202450,000,000£50.00m£1

Officers

Officers

1 active 2 resigned
Status
Jonathan Richard SymondsDirectorBritishUnited Kingdom6722 Oct 2013Active

Shareholders

Shareholders (1)

Secretary Of State For Health And Social Care
100.0%
737,700,001

Persons with Significant Control

Persons with Significant Control (1)

1 Active

The Secretary Of State For Health And Social Care

Unknown

Active
Notified 14 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
Dawson Hall, Charterhouse Square, London (EC1M 6BQ) ISLINGTON
Leasehold-26 Oct 2015
Part Of Ground Floor, Dawson Hall, Charterhouse Square, London (EC1M 6BQ) ISLINGTON
Leasehold-28 May 2014
Dawson Hall, Charterhouse Square, London (EC1M 6BQ)
Leasehold
Added 26 Oct 2015
District ISLINGTON
Part Of Ground Floor, Dawson Hall, Charterhouse Square, London (EC1M 6BQ)
Leasehold
Added 28 May 2014
District ISLINGTON

Documents

Company Filings

DateCategoryDescriptionDocument
7 Apr 2026OfficersTermination of Matthew Brown as director on 2026-04-02
3 Feb 2026CapitalAllotment of shares (GBP 897,700,001) on 2026-01-30
27 Jan 2026OfficersAppointment of Dr Gail Elizabeth Marzetti as director on 2026-01-26
25 Jan 2026OfficersChange to director Ms Nicola Blackwood-Bate on 2026-01-22
25 Jan 2026OfficersChange to director Baroness Nicola Blackwood on 2026-01-22
7 Apr 2026 Officers

Termination of Matthew Brown as director on 2026-04-02

3 Feb 2026 Capital

Allotment of shares (GBP 897,700,001) on 2026-01-30

27 Jan 2026 Officers

Appointment of Dr Gail Elizabeth Marzetti as director on 2026-01-26

25 Jan 2026 Officers

Change to director Ms Nicola Blackwood-Bate on 2026-01-22

25 Jan 2026 Officers

Change to director Baroness Nicola Blackwood on 2026-01-22

Recent Activity

Latest Activity

Termination of Matthew Brown as director on 2026-04-02

2 weeks ago on 7 Apr 2026

Allotment of shares (GBP 897,700,001) on 2026-01-30

2 months ago on 3 Feb 2026

Appointment of Dr Gail Elizabeth Marzetti as director on 2026-01-26

2 months ago on 27 Jan 2026

Change to director Ms Nicola Blackwood-Bate on 2026-01-22

2 months ago on 25 Jan 2026

Change to director Baroness Nicola Blackwood on 2026-01-22

2 months ago on 25 Jan 2026